Fortrea Holdings (FTRE) Payables (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Payables came in at $54.2 million in Q2 2026, down 41.47% on a YoY basis from $92.6 million in Q2 2025, and down 23.45% quarter-over-quarter from $70.8 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Payables (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Payables for 5 consecutive years, with $54.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Payables fell 41.47% year-over-year to $54.2 million; the trailing twelve-month figure through Jun 2026 stood at $54.2 million (down 41.47% YoY), and the FY2025 full-year result was $29.7 million, down 78.51% from the prior year.
- Payables slipped to $54.2 million in Q2 2026 per FTRE's latest filing, from $70.8 million in the prior quarter.
- Across five years, Payables topped out at $144.2 million in Q2 2024 and bottomed at $29.7 million in Q4 2025.
- Historically, Payables has averaged $100.4 million across 5 years, with a median of $107.8 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Payables surged 63.07% in 2023, then slumped 78.51% in 2025.
- Over 5 years, Payables stood at $81.5 million in 2022, then soared by 63.07% to $132.9 million in 2023, then advanced by 3.99% to $138.2 million in 2024, then plunged by 78.51% to $29.7 million in 2025, then surged by 82.49% to $54.2 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $54.2 million, $70.8 million, and $29.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 37.53 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 140.98 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 118.24 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 54.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 57.10 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 9.58 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 6.90 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 3.05 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.20 Mn |
| Mar 31, 2026 | 70.80 Mn |
| Dec 31, 2025 | 29.70 Mn |
| Sep 30, 2025 | 49.50 Mn |
| Jun 30, 2025 | 92.60 Mn |
| Mar 31, 2025 | 110.20 Mn |
| Dec 31, 2024 | 138.20 Mn |
| Sep 30, 2024 | 137.60 Mn |
| Jun 30, 2024 | 144.20 Mn |
| Mar 31, 2024 | 131.30 Mn |
| Dec 31, 2023 | 132.90 Mn |
| Sep 30, 2023 | 128.30 Mn |
| Jun 30, 2023 | 105.30 Mn |
| Dec 31, 2022 | 81.50 Mn |